Your browser doesn't support javascript.
loading
Who should be first in line for the COVID-19 vaccine? Surveys in 13 countries of the publics preferences for prioritisation
Raymond Duch; Laurence S J Roope; Mara Violato; Matias F Becerra; Thomas Robinson; Jean-Francois Bonnefon; Jorge Friedman; Peter Loewen; Pavan Mamidi; Alessia Melegaro; Mariana Blanco; Juan Vargas; Julia Seither; Paolo Candio; Ana G Cruz; Xinyang Hua; Adrian Barnett; Philip Clarke.
Afiliação
  • Raymond Duch; University of Oxford
  • Laurence S J Roope; University of Oxford)
  • Mara Violato; University of Oxford
  • Matias F Becerra; Universidad de Chile
  • Thomas Robinson; University of Durham
  • Jean-Francois Bonnefon; Toulouse School of Economics
  • Jorge Friedman; Universidad de Santiago de Chile
  • Peter Loewen; University of Toronto
  • Pavan Mamidi; Center for Social and Behavioral Change
  • Alessia Melegaro; University of Bocconi
  • Mariana Blanco; Universidad del Rosario
  • Juan Vargas; Universidad del Rosario
  • Julia Seither; Universidad del Rosario
  • Paolo Candio; University of Oxford
  • Ana G Cruz; University of Oxford
  • Xinyang Hua; University of Melbourne
  • Adrian Barnett; Queensland University of Technology
  • Philip Clarke; University of Oxford
Preprint em En | PREPRINT-MEDRXIV | ID: ppmedrxiv-21250866
ABSTRACT
How does the public want a COVID-19 vaccine to be allocated? We conducted a conjoint experiment asking 15,536 adults in 13 countries to evaluate 248,576 profiles of potential vaccine recipients that varied randomly on five attributes. Our sample includes diverse countries from all continents. The results suggest that in addition to giving priority to health workers and to those at high risk, the public favours giving priority to a broad range of key workers and to those on lower incomes. These preferences are similar across respondents of different education levels, incomes, and political ideologies, as well as across most surveyed countries. The public favoured COVID-19 vaccines being allocated solely via government programs, but were highly polarized in some developed countries on whether taking a vaccine should be mandatory. There is a consensus among the public on many aspects of COVID-19 vaccination which needs to be taken into account when developing and communicating roll-out strategies.
Licença
cc_by_nc_nd
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Experimental_studies / Observational_studies / Prognostic_studies / Rct Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Experimental_studies / Observational_studies / Prognostic_studies / Rct Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint